Table 2. Receptors expression on PMN from HD and XLA patients.

	HD		XLA before IVIg		XLA after IVIg
Receptor	Unstimulated MFI	Stimulated MFI	Unstimulated MFI	Stimulated MFI	Unstimulated MFI	Stimulated MFI
CD181	337.3 ± 16.8	205.8 ± 102.9*	361.5 ± 57.3	198 ± 76.5**	317.5 ± 98.3	169 ± 69.3**
CD66b	333.5 ± 29	1310 ± 162.6*	484.7 ± 66	1365.7 ± 287.7**	486.7 ± 116.4	1240 ± 654**
CD11b	20.7 ± 5.7	50.6 ± 0.8*	28.7 ± 9.4	49.3 ± 22.7**	24.8 ± 4.5	51.3 ± 29.5**
CD11c	20 ± 7.7	48.7 ± 11*	24.8 ± 10.5	50.4 ± 14.4**	24.4 ± 10.6	47.9 ± 13.6**
CD16	3555.6 ± 1144.5	4336.6 ± 1539.5*	3012 ± 952.8	3758.8 ± 1035.2**	2753.8 ± 794.4	3594.6 ± 1033.6**
Siglec 9	56.1 ± 15.5	99 ± 38.7*	61.7 ± 11.9	97.2 ± 27.4**	61.2 ± 16.1	81.7 ± 28.1**

Values are expressed as Mean Fluorescence Intensity (MFI).

* p 0.005,

** p 0.03